Zynex Announces Completion of Its Laser Pulse Oximetry Trial

Core Insights - Zynex, Inc. has completed its clinical verification trial for the NiCO™ pulse oximeter, a significant step towards FDA submission for market clearance [1][2][5] - The NiCO pulse oximeter employs advanced laser technology for direct measurement of blood oxygenation, addressing inaccuracies found in traditional LED-based devices, particularly for individuals with darker skin [3][4] - The company aims to penetrate the multi-billion dollar pulse oximetry market with the NiCO product line, emphasizing its precision, accuracy, and safety as key competitive advantages [4][6] Company Developments - The completion of the verification study is described as a pivotal event for Zynex Monitoring Solutions, marking the transition to final testing before the FDA submission [2][5] - Zynex's President highlighted the collaborative effort behind the study's success and the company's readiness to submit for FDA clearance [5] - The CEO expressed excitement about entering a mature and growing market with the NiCO product, which is expected to leverage its innovative capabilities [6]